Duality Advisers, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$25.16 - $41.38 $252,103 - $414,627	-10,020 Reduced 48.42%	10,676 $380,000
Q1 2023 Jun 27, 2023	BUY	$23.68 - $38.51 $490,081 - $797,002	20,696 New	20,696 $525,000
Q3 2022 Nov 03, 2022	BUY	$29.63 - $48.31 $447,472 - $729,577	15,102 Added 36.12%	56,917 $1.88 Million
Q2 2022 Aug 08, 2022	BUY	$27.79 - $50.61 $821,583 - $1.5 Million	29,564 Added 241.32%	41,815 $1.47 Million
Q1 2022 May 09, 2022	BUY	$39.62 - $69.97 $485,384 - $857,202	12,251 New	12,251 $563,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.